We started off slowly this week in terms of Q4 earnings results and economic data, but are catching up fast this morning. Aside from Beyond Meat (BYND - Free Report) shooting up 30% in today’s pre-market on a joint venture with PepsiCo (PEP - Free Report) to create plant-based snacks (terms of the deal not yet disclosed), we also get a new Case-Shiller home price index report.
The Case-Shiller numbers are from November, making it a lagging indicator on the already robust housing market. Thus, month-over-month and year-over-year gains were expected, and the report did not disappoint: +9.5% on the headline was an 110 basis-point improvement month over month, with the 20-City survey at +9.1% — its largest read since May 2014. Record-low interest rates, along with Americans moving away from the big cities, helped lead the charge. Tops again in November were Phoenix +13.8%, Seattle +12.7% and San Diego +12.3%.
Speaking of housing, homebuilder D.R. Horton (DHI - Free Report) put up better-than-expected numbers on both its top and bottom lines in its Q4 release this morning: $2.14 per share was nicely ahead of the $1.72 in the Zacks consensus, while $5.93 billion in quarterly revenues topped expectations by 6%. The numbers storm past the year-ago 99 cents per share on $4.02 billion in sales, and marks the eighth straight quarterly beat for the Zacks Rank #2 (Buy)-rated stock.
Johnson & Johnson (JNJ - Free Report) , the healthcare products giant with a Covid-19 vaccine candidate still in development, also posted positive beats: $1.86 per share on $22.48 billion outpaced expectations by 5 cents per share on the bottom line and 4% on the top. In the year-ago quarter, J&J posted $1.88 per share and $20.75 billion — demonstrating a clear money windfall for the company over the prolonged pandemic period. Shares are up 2% in today’s pre-market.
3M (MMM - Free Report) continues the Q4 beat-parade with $2.38 per share in earnings surpassing the $2.19 analysts were looking for. Sales in the quarter reached $8.58 billion, up 1.12% from expectations. Both numbers are improvements year over year, as well, further stringing out 3M’s comeback story. Shares had been down 3.3% year to date, but have made 1.7% of that back so far in early trading.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
We started off slowly this week in terms of Q4 earnings results and economic data, but are catching up fast this morning. Aside from Beyond Meat (BYND - Free Report) shooting up 30% in today’s pre-market on a joint venture with PepsiCo (PEP - Free Report) to create plant-based snacks (terms of the deal not yet disclosed), we also get a new Case-Shiller home price index report.
The Case-Shiller numbers are from November, making it a lagging indicator on the already robust housing market. Thus, month-over-month and year-over-year gains were expected, and the report did not disappoint: +9.5% on the headline was an 110 basis-point improvement month over month, with the 20-City survey at +9.1% — its largest read since May 2014. Record-low interest rates, along with Americans moving away from the big cities, helped lead the charge. Tops again in November were Phoenix +13.8%, Seattle +12.7% and San Diego +12.3%.
Speaking of housing, homebuilder D.R. Horton (DHI - Free Report) put up better-than-expected numbers on both its top and bottom lines in its Q4 release this morning: $2.14 per share was nicely ahead of the $1.72 in the Zacks consensus, while $5.93 billion in quarterly revenues topped expectations by 6%. The numbers storm past the year-ago 99 cents per share on $4.02 billion in sales, and marks the eighth straight quarterly beat for the Zacks Rank #2 (Buy)-rated stock.
Johnson & Johnson (JNJ - Free Report) , the healthcare products giant with a Covid-19 vaccine candidate still in development, also posted positive beats: $1.86 per share on $22.48 billion outpaced expectations by 5 cents per share on the bottom line and 4% on the top. In the year-ago quarter, J&J posted $1.88 per share and $20.75 billion — demonstrating a clear money windfall for the company over the prolonged pandemic period. Shares are up 2% in today’s pre-market.
3M (MMM - Free Report) continues the Q4 beat-parade with $2.38 per share in earnings surpassing the $2.19 analysts were looking for. Sales in the quarter reached $8.58 billion, up 1.12% from expectations. Both numbers are improvements year over year, as well, further stringing out 3M’s comeback story. Shares had been down 3.3% year to date, but have made 1.7% of that back so far in early trading.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on JNJ - FREE
Get the latest research report on MMM - FREE
Get the latest research report on PEP - FREE
Get the latest research report on DHI - FREE
Get the latest research report on BYND - FREE